Stemline Therapeutics, Inc.

Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Home

	The Company
	Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing oncology compounds directed towards cancer stem cell targets.

	Platform
	Stemline Therapeutics has developed a Discovery Platform called "StemScreen^®" to identify novel compounds that target and kill CSCs.

News
&
Events

7/20/2010
CEO of Stemline to present at Drug Development Conference Aug. 4, 2010

3/21/2010
Stemline CEO invited speaker at Cancer Stem Cell conference Mar. 24-25, 2010

12/4/2009
Stemline announces presentation of SL-401 and SL-501 activity in CML at ASH